Filing Details

Accession Number:
0000950170-24-026009
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-03-05 16:27:51
Reporting Period:
2024-03-01
Accepted Time:
2024-03-05 16:27:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1000228 Henry Schein Inc HSIC Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047) 113136595
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1194347 P James Breslawski C/O Henry Schein, Inc.
135 Duryea Road
Melville NY 11747
Vice Chairman, President No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.01 Per Share Disposition 2024-03-01 3,271 $76.88 198,284 No 4 F Direct
Common Stock, Par Value $0.01 Per Share Acquisiton 2024-03-04 17,092 $0.00 215,376 No 4 A Direct
Common Stock, Par Value $0.01 Per Share Disposition 2024-03-04 2,907 $76.50 212,469 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 A Direct
No 4 S Direct
Footnotes
  1. Represents the surrender of shares to the Issuer to satisfy the reporting person's tax withholding obligation upon the vesting of the reporting person's March 3, 2020 grant of time-based restricted stock/units. (Actual vesting date of March 3, 2024 was a non-business day so vesting occurred on the preceding business day.)
  2. Grant of restricted stock units (RSU) pursuant to the Issuer's 2020 Stock Incentive Plan. Subject to certain exceptions, 50% will vest subject to (x) Issuer's achievement of a specified performance goal and (y) reporting person's continued perf. of services for the Issuer. 50% will vest subject to (x) passage of a specified period of time and (y) reporting person's continued perf. of services for the Issuer. With respect to the performance-based RSU, if the continued service requirement is satisfied and achievement of the perf. goal (x) exceeds 100% of target, the Issuer may issue additional vested shares of common stock in an amount that corresponds to the incremental percentage of the performance goal achieved in excess of 100% of target or (y) is less than 100% of target, the reporting person will surrender to the Issuer shares of common stock in an amount that corresponds to the incremental percentage of the performance goal achieved that is below 100% of target (shortfall).
  3. The sale transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 19, 2023.